Literature DB >> 17401173

A real-time PCR method to rapidly titer adenovirus stocks.

Maria A Thomas1, Drew L Lichtenstein, Peter Krajcsi, William S M Wold.   

Abstract

A critical step in working with adenovirus (Ad) and its vectors is the accurate, reproducible, sensitive, and rapid measurement of the amount of virus present in a stock. Titration methods fall into one of two categories: determination of either the infectious or the particle (infectious plus noninfectious) titer. Determining the infectious titer of a virus stock by plaque assay has important limitations, including cell line-, researcher-, and laboratory-dependent variation in titer, and the length of time required to perform the assay (2-4 wk). A major drawback of particle titration methods is the lack of consistent correlation between the resultant titer and the infectious titer. To overcome these problems, a rapid, sensitive, and reproducible real-time polymerase chain reaction (PCR) assay was developed that detects encapsidated full-length genomes. Importantly, there is a linear correlation between the titer determined by the realtime PCR assay and the infectious titer determined by a plaque assay. This chapter provides step-by-step guidance for preparing viral DNA, conducting the real-time PCR assay, and using the resultant data to calculate a viral titer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401173     DOI: 10.1385/1-59745-166-5:185

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  7 in total

1.  Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors.

Authors:  Di Yu; Chuan Jin; Justyna Leja; Nadim Majdalani; Berith Nilsson; Fredrik Eriksson; Magnus Essand
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Standard free droplet digital polymerase chain reaction as a new tool for the quality control of high-capacity adenoviral vectors in small-scale preparations.

Authors:  Philip Boehme; Thorsten Stellberger; Manish Solanki; Wenli Zhang; Eric Schulz; Thorsten Bergmann; Jing Liu; Johannes Doerner; Armin E Baiker; Anja Ehrhardt
Journal:  Hum Gene Ther Methods       Date:  2015-02       Impact factor: 2.396

3.  Transcriptional regulation of the intestinal nuclear bile acid farnesoid X receptor (FXR) by the caudal-related homeobox 2 (CDX2).

Authors:  Salvatore Modica; Marica Cariello; Annalisa Morgano; Isabelle Gross; Maria Carmela Vegliante; Stefania Murzilli; Lorena Salvatore; Jean-Noel Freund; Carlo Sabbà; Antonio Moschetta
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

4.  Development of a method for effective amplification of human adenovirus 40.

Authors:  Satoshi Yamasaki; Yoshiaki Miura; Eric Brown; Julia Davydova; Masato Yamamoto
Journal:  Arch Virol       Date:  2010-05-21       Impact factor: 2.574

5.  Mutations in the GM1 binding site of simian virus 40 VP1 alter receptor usage and cell tropism.

Authors:  Thomas G Magaldi; Michael H C Buch; Haruhiko Murata; Kimberly D Erickson; Ursula Neu; Robert L Garcea; Keith Peden; Thilo Stehle; Daniel DiMaio
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

6.  Virion assembly factories in the nucleus of polyomavirus-infected cells.

Authors:  Kimberly D Erickson; Cedric Bouchet-Marquis; Katie Heiser; Eva Szomolanyi-Tsuda; Rabinarayan Mishra; Benjamin Lamothe; Andreas Hoenger; Robert L Garcea
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

7.  Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection.

Authors:  Andreea Popa; Wei Zhang; Megan S Harrison; Kylia Goodner; Teymur Kazakov; Edward C Goodwin; Alex Lipovsky; Christopher G Burd; Daniel DiMaio
Journal:  PLoS Pathog       Date:  2015-02-18       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.